Oruka Therapeutics CMO Joana Goncalves disposes of USD 552,429 common shares

Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc.

ORKA

0.00
  • Oruka Therapeutics Chief Medical Officer Joana Goncalves reported option exercises totaling 7,000 shares on June 15, 2026 at $6.84 and $7.8.
  • Goncalves reported open-market sales totaling 7,000 shares on June 15, 2026 at weighted-average prices of $68.38 to $70.62.
  • She also sold 947 shares at $69.69 under an automatic sell-to-cover process tied to tax withholding.
  • Directly held common stock ended at 32,718 shares following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oruka Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000907654-26-000063), on June 15, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.